Cross-sectional analysis evaluates pap smear and VIA effectiveness in detecting cervical cancer, highlighting HPV associations.
Background: Cervical cancer remains a leading cause of morbidity among Indian women, especially due to inadequate screening coverage in rural areas. Aims And Objectives: To compare the effectiveness of VIA and Pap smear in cervical cancer screening and confirm HPV involvement using DNA testing. Method: A cross-sectional study was conducted on 1200 symptomatic women over 18 years using VIA, Pap smear, and HPV DNA testing. Results: Pap smear detected abnormalities in 12.5% of participants, while VIA showed 11% positivity. Combined testing achieved a diagnostic accuracy of 97.35%, with Pap smear alone at 60.65% and VIA at 50.32%. HPV DNA testing demonstrated 78.06% diagnostic accuracy, with Type 16 being the most prevalent strain (56.4%). Rural and lower socioeconomic groups showed higher test positivity. Statistically significant associations were found between HPV positivity, family history, and low socioeconomic status. Conclusion: VIA and Pap smear are effective, especially in combination. HPV DNA testing adds diagnostic value and confirms viral etiology.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: